Home
News
Create
Screeners
Insights
Earkart
140.
50
-140.50
(-100.00%)
Market Cap
₹193.20 Cr
PE Ratio
-
Industry
Healthcare
Buy
Sell
Company Performance:
1D
-100.00%
1M
-100.00%
6M
-100.00%
1Y
-100.00%
5Y
-100.00%
View Company Insights
Latest news about Earkart
Earkart Limited Board Approves Land Acquisition and Pharmaceutical Business Expansion
3 days ago
Earkart Limited's board approved acquisition of land for manufacturing facility and pharmaceutical business during meeting on 11 March 2026. The company acknowledged the meeting was held on short notice due to urgent matters, causing delayed BSE intimation under SEBI regulations. Management assured stakeholders that compliance measures are being strengthened for future proceedings.
Earkart Limited Incorporates US Subsidiary Earkart Inc. for American Market Expansion
Feb 26, 2026
Earkart Limited Secures ₹4.13 Crore Government Order from ALIMCO via GeM Portal
Feb 14, 2026
Earkart Limited Secures ₹2.77 Crore Government Contract Through GeM Portal
Jan 14, 2026
Earkart Board Reviews Turtle Maarks LLP Investment
Dec 18, 2025
More news about Earkart
09
Dec 25
Earkart Limited Reports Mixed H1 Results: Private Sector Growth Offsets Government Delays
Earkart Limited reported a 5% YoY revenue decline to ₹22.00 crores in H1 due to delayed government tenders. However, private sector growth of 25% partially offset the impact. The company secured ₹9.00 crores in new orders for H2 and aims to expand its OMNI audiometer installations from 56 to 110 clinics by March. Management expects a strong H2 performance to potentially compensate for the H1 shortfall.
20
Nov 25
Earkart Limited Secures ₹6.25 Crore Government Contract for Digital Hearing Aid Components
Earkart Limited has been awarded a ₹6.25 crore contract by the Government e-Marketplace (GeM) to supply 26,000 sets of components for BTE Digital Hearing Aid kits to ALIMCO, under the Ministry of Social Justice and Empowerment. The contract, awarded on November 19, is expected to positively impact the company's revenue. Earkart disclosed this information to BSE Limited on November 20, in compliance with SEBI regulations.
15
Nov 25
Earkart Limited Announces Board Decisions and Q2 FY2026 Results Post-IPO
Earkart Limited (BSE: 544549) held a board meeting on November 14, 2025, approving several important measures. The board authorized an ESOP scheme application, appointed N Kothari & Associates as Secretarial Auditor for FY 2025-26, and approved unaudited financial results for Q2 and H1 ending September 30, 2025. The company completed its IPO, issuing 3,315,000 equity shares at Rs 135 per share, increasing its paid-up capital to Rs 1,375.39 lakhs and generating a share premium of Rs 4,097.65 lakhs. Earkart has committed to transparency by ensuring timely disclosure of these developments to BSE Limited and making detailed financial results available on its website.
27
Oct 25
Earkart's OMNI Platform Showcased at Global Otolaryngology Conference
Earkart Limited presented its next-generation OMNI platform, a remote diagnostic solution for ENT care, at the world's largest otolaryngology conference in Indianapolis, USA. The event, attended by over 5,000 specialists from more than 75 countries, featured live demonstrations of OMNI's real-time diagnostics and remote consultation capabilities. The platform garnered significant interest from ENT specialists, audiologists, and healthcare leaders, suggesting potential for expansion across North America, Europe, the Middle East, and emerging healthcare markets. Earkart, a hearing healthcare solutions provider, operates with a business model combining technology, accessibility, and social impact, with a revenue split of 69% government and 29% private.
Earkart
140.
50
-
140.
50
(-
100.
00
%)
1 Year Returns:
-100.00%
Industry Peers
Poly Medicure
1,260.20
(-
3.
97
%)
Tarsons Products
192.78
(-
0.
76
%)
Laxmi Dental
178.51
(-
2.
81
%)
Osel Devices
463.15
(-
4.
90
%)
Vasa Denticity
390.45
(-
0.
95
%)
Fabtech Technologies
141.50
(-
5.
60
%)
Prevest Denpro
408.10
(+
1.
90
%)
Aprameya Engineering
219.00
(-
4.
78
%)
Hemant Surgical Industries
266.00
(-
2.
21
%)
Nureca
257.45
(-
3.
90
%)
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/ Block Deals
Stock Rental via SLBM
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation
IPO